<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Combining systems pharmacology, transcriptomics, proteomics, and metabolomics to dissect the therapeutic mechanism of Chinese herbal Bufei Jianpi formula for application to COPD</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-03-15">15 March 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peng</forename><surname>Zhao</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Key laboratory of Chinese Internal Medicine</orgName>
								<orgName type="institution">henan University of Traditional Chinese Medicine</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Collaborative Innovation Center for respiratory Disease Diagnosis and Treatment and Chinese Medicine Development of henan Province</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Liping</forename><surname>Yang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Key laboratory of Chinese Internal Medicine</orgName>
								<orgName type="institution">henan University of Traditional Chinese Medicine</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Collaborative Innovation Center for respiratory Disease Diagnosis and Treatment and Chinese Medicine Development of henan Province</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jiansheng</forename><surname>Li</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Collaborative Innovation Center for respiratory Disease Diagnosis and Treatment and Chinese Medicine Development of henan Province</orgName>
							</affiliation>
							<affiliation key="aff0">
								<orgName type="department">Key laboratory of Chinese Internal Medicine</orgName>
								<orgName type="institution">henan University of Traditional Chinese Medicine</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Collaborative Innovation Center for respiratory Disease Diagnosis and Treatment and Chinese Medicine Development of henan Province</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of respiratory Diseases</orgName>
								<orgName type="institution">The First affiliated hospital of henan University of Traditional Chinese Medicine</orgName>
								<address>
									<settlement>Zhengzhou</settlement>
									<country>People&apos;s republic of China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ya</forename><surname>Li</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Key laboratory of Chinese Internal Medicine</orgName>
								<orgName type="institution">henan University of Traditional Chinese Medicine</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Collaborative Innovation Center for respiratory Disease Diagnosis and Treatment and Chinese Medicine Development of henan Province</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yange</forename><surname>Tian</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Key laboratory of Chinese Internal Medicine</orgName>
								<orgName type="institution">henan University of Traditional Chinese Medicine</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Collaborative Innovation Center for respiratory Disease Diagnosis and Treatment and Chinese Medicine Development of henan Province</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">henan University of Traditional Chinese Medicine</orgName>
								<address>
									<addrLine>1 Jinshui road</addrLine>
									<postCode>450046</postCode>
									<settlement>Zhengzhou</settlement>
									<country>People&apos;s republic of China</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Combining systems pharmacology, transcriptomics, proteomics, and metabolomics to dissect the therapeutic mechanism of Chinese herbal Bufei Jianpi formula for application to COPD</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-03-15">15 March 2016</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.2147/COPD.S100352</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T22:54+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Bufei Jianpi formula</term>
					<term>system-level therapeutic mechanism</term>
					<term>transcriptomic</term>
					<term>proteomic</term>
					<term>metabolomic</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Bufei Jianpi formula (BJF) has long been used as a therapeutic agent in the treatment of COPD. Systems pharmacology identified 145 active compounds and 175 potential targets of BJF in a previous study. Additionally, BJF was previously shown to effectively prevent COPD and its comorbidities, such as ventricular hypertrophy, by inhibition of inflammatory cytokine production, matrix metalloproteinases expression, and other cytokine production, in vivo. However, the system-level mechanism of BJF for the treatment of COPD is still unclear. The aim of this study was to gain insight into its system-level mechanisms by integrating transcriptomics, proteomics, and metabolomics together with systems pharmacology datasets. Using molecular function, pathway, and network analyses, the genes and proteins regulated in COPD rats and BJF-treated rats could be mainly attributed to oxidoreductase activity, antioxidant activity, focal adhesion, tight junction, or adherens junction. Furthermore, a comprehensive analysis of systems pharmacology, transcript, protein, and metabolite datasets is performed. The results showed that a number of genes, proteins, metabolites regulated in BJF-treated rats and potential target proteins of BJF were involved in lipid metabolism, cell junction, oxidative stress, and inflammatory response, which might be the system-level therapeutic mechanism of BJF treatment.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>COPD is a serious health problem characterized primarily by irreversible airflow limitation and systemic inflammation, which represents a substantial economic burden in the world. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref> Despite great progress in the treatment of COPD, drug therapies have not changed significantly. <ref type="bibr" target="#b2">3</ref> Therefore, the development of novel therapeutic drugs and strategies to improve the efficacy in treating this deadly disease is still urgently needed.</p><p>Bufei Jianpi formula (BJF), a traditional Chinese medicine (TCM), has provided effective relief of symptoms in patients with COPD. Our clinical study demonstrated that BJF had extensive pharmacological effects on patients with COPD, such as alleviating the clinical symptoms of stable COPD, reducing the exacerbation frequency, delaying acute exacerbation, and improving pulmonary function and exercise capacity. <ref type="bibr" target="#b3">4</ref> Increasing evidences demonstrate that, in treating complex illnesses, including COPD, treatment formula containing multiple drugs with distinct but related mechanisms can usually exert synergistic therapeutic effects and amplify the therapeutic efficacies of each agent. <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6</ref> In the previous study, we constructed a systems pharmacological model by combining active compound prediction, target prediction, and network pharmacology to clarify the active compounds and therapeutic mechanism of BJF. Systems pharmacology successfully identified 145 bioactive ingredients from BJF and predicted 175 potential targets of the active components contained in BJF. Moreover, we experimentally demonstrated that BJF was effective for the treatment of COPD and ventricular hypertrophy due to its inhibitory effect on the inflammatory cytokine, and hypertrophic factors expression, protease-antiprotease imbalance, and collagen deposition, in vivo. <ref type="bibr" target="#b6">7</ref> Systems pharmacology, as an understanding of the function of the biological system, provided a systemwide view of the therapeutic mechanism of BJF in treating COPD rats. However, we should provide more experimental evidences to validate the systems pharmacology predictions at system level.</p><p>Transcriptomics-proteomics-metabolomics-profiling techniques provide holistic approaches to reveal the complex biological processes and function of herbal compound recipe. <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref> Transcriptomics has been used in many in vivo studies to find the whole genome, which, however, cannot provide the details of the alternative splicing or even protein expression itself. Proteomics is a promising approach to directly study the expressed proteins and protein functions in a cellular context. Moreover, metabolomics provides the metabolic information, that is, the consequence of the transcriptome and proteome. <ref type="bibr" target="#b10">11</ref> Thus, comprehensive analyses of the transcriptomics, proteomics, and metabolomics datasets have the potential to provide a system view of the complex biological processes and function of herbal compounds. <ref type="bibr" target="#b11">12</ref> We previously analyzed metabolite changes in lung tissues of COPD rats, and identified 30 strongly regulated metabolites resulting from intervention by BJF treatment. <ref type="bibr" target="#b12">13</ref> In this study, we further analyzed the molecular effect of BJF on COPD rats using the datasets of transcripts and proteins derived from lung tissues. Finally, the aim of this study was to integrate systems pharmacology, transcriptomics, proteomics, and metabolomics data streams, which provided a system picture of molecular mechanisms of BJF in treating COPD rats.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Chemicals and animals</head><p>Klebsiella pneumoniae (strain ID: 46114) was purchased from the National Center for Medical Culture Collection (CMCC, Beijing, People's Republic of China). Tobacco (Hongqi Canal ® Filter tip cigarette; tobacco type, tar: 10 mg; nicotine content: 1.0 mg; carbon monoxide: 12 mg) was obtained from China Tobacco Henan Industrial Co., Ltd (Zhengzhou, People's Republic of China). Thirty-two Sprague Dawley rats (16 male and 16 female; 200±20 g) were purchased from the Experimental Animal Center of Henan Province (Zhengzhou, People's Republic of China). The animals were reared in cages with free access to food and water under standard laboratory conditions. All animals were handled with humane care throughout the experiment.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>COPD model, drug administration, and lung samples</head><p>COPD rat model was prepared as described earlier. Briefly, 22 rats were placed in a closed box exposed to tobacco and repeated K. pneumoniae infections. <ref type="bibr" target="#b13">14</ref> On week 9, COPD rats were randomly divided into two groups with ten rats in each group. COPD rats were intragastrically treated with normal saline (2 mL) and BJF at the dose of 4.84 g/kg per day. The healthy control rats were also administered intragastrically normal saline (2 mL) for the same amount of time. All the rats were sacrificed at week 20. The lung tissues were shock-frozen in liquid nitrogen and stored at -80°C before use.</p><p>The components of BJF were as follows: Astragali Radix 15 g, Polygonati Rhizoma 15 g, Codonopsis Radix 15 g, Atractylodis Macrocephalae Rhizoma 12 g, Poria 12 g, Fritillariae Thunbergii Bulbus 9 g, Magnoliae Officinalis Cortex 9 g, Citri Reticulatae Pericarpium 9 g, Asteris Tatarici Radix 9 g, Pheretima 12 g, Ardisiae Japonicae Herba 15 g, and Epimedii Herba 6 g. The herbs were identified and prepared in fluid extract according to the standard operating procedure. The experimental protocol was approved by the Experimental Animal Care and Ethics Committee of the First Affiliated Hospital, Henan University of Traditional Chinese Medicine. The animal experiments were conducted in accordance with guidelines of the Committee on the Care and Use of Laboratory Animals of the First Affiliated Hospital, Henan University of Traditional Chinese Medicine, People's Republic of China.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>gene expression analyses with microarrays</head><p>For microarray analysis, six rats were used for each group for microarray study. Total RNA was isolated from lung tissues of six rats from each of the three experimental groups by TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA) and purified using a Qiagen RNeasy Micro Kit (Qiagen NV, Venlo, the Netherlands). RNA integrity was checked using standard agarose gel electrophoresis and ethidium bromide staining.</p><p>Purified RNA was polymerase chain reaction amplified using a First Strand cDNA Synthesis Kit (Hoffman-La Roche Ltd., Basel, Switzerland) and labeled using an Agilent Quick Amp Kit (Agilent Technologies, Santa Clara, CA, USA). Then, RNA was hybridized with Agilent Whole Rat Genome Oligo Microarray (4×44 K) and washed. Finally, the slides were analyzed using an Agilent DNA microarray scanner (part number G2505B).</p><p>The raw microarray data were further analyzed using Agilent GeneSpring GX software Version 11.0. Processed data were subsequently filtered for significant detection (Student's t-test screening, P,0.05) and differential expression versus COPD model rats (fold change, |log ratio| .1).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Protein expression analysis</head><p>Lung tissue protein was isolated from the three experimental groups. In each group, six rats were taken out for the analysis of protein expression. In brief, the lung tissues were lysed using the lysis buffer containing 4% sodium dodecyl sulfate, 0.1 M dithiothreitol, and 0.1 M Tris pH 8.0 and homogenized in a mechanical homogenizer (Retsch Technology, Haan, Germany). The lysates were clarified by centrifugation and then stored at -80°C.</p><p>For proteolytic digestion, trypsin (Hoffman-La Roche Ltd.) solution (protein/trypsin ratio 1:30) was added to the protein solution and incubated for 24 hours at 37°C. To label tryptic peptides with 8-plex iTRAQ labeling reagents (ABSciex, Darmstadt, Germany), each of the samples was reconstituted with isopropanol individually, and the labeling procedure was performed according to the manufacturer's protocol.</p><p>For strong cation exchange fractionation, buffers A (10 mM KH 2 PO 4 in 25% acetonitrile [ACN] at pH 3) and B (10 mM KH 2 PO 4 and 2 M KCl in 25% ACN at pH 3) were used as the mobile phase. The peptide mixtures were dissolved in buffer A and then loaded onto a PolySULFOETHYL A column. Peptides were fractionated using an 86-minute gradient from 0% to 100% of buffer B and monitored at optical density 214 nm. Fractions were collected every minute from the retention times of 8-58 minutes. Then, the fractions were dried, dissolved in 0.1% formic acid (FA), and used for liquid chromatographymass spectrometry (LC-MS) analysis.</p><p>LC-MS/MS analysis was performed on a nano liquid chromatograph (Shimadzu, Kyoto, Japan) coupled online to a quadrupole time-of-flight mass spectrometer (Bruker Daltonics, Bremen, Germany). For the LC-MS/MS analysis, water with 0.1% FA and ACN with 0.1% FA were used as the mobile phase. The peptide sample was injected into a pulled tip column (15 cm ×100 μm inner diameter) containing C18 Reprosil, 5 μm particles (Nikkyo Technos, Tokyo, Japan), and separated online using increasing amounts of acetonitrile containing 0.1% FA (mobile phase B) at 300 nL/min. Gradient conditions were as follows: 5%-34% B (0-25 minutes), 34%-60% B (25-30 minutes), 80% B held for 4 minutes, and 5%-80% B (1 minute).</p><p>The identification results were obtained from Mascot. The criteria used for protein quantitation were as follows: two unique peptide hits, two quantitative peptides, and disabling of outlier removal. The reporter ion ratio for each identified peptide was determined by Mascot. The loess and global median normalization were used to process the proteomics data. Data were log 2 transformed and analyzed on both peptide and protein level. Statistical significance of observed fold-change ratios was determined by one sample t-test. P-values ,0.05 were considered statistically significant for proteins. Fold change higher than 1.0 is for upregulation or lower than 1.0 is for downregulation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>gene/protein set enrichment, network, and pathway analyses</head><p>The molecular function of transcripts and proteins was explored by BiNGO, a Cytoscape v3.1.1 plugin. <ref type="bibr" target="#b14">15</ref> Pathway enrichment analysis of transcripts and proteins was performed using the Database for Annotation, Visualization and Integrated Discovery and Kyoto Encyclopedia of Genes and Genomes database. We considered regulated pathways only as statistically significant, if the P-value was #0.05. We applied Metscape to analyze the integrated pathway of gene, protein, and metabolomics data. <ref type="bibr" target="#b15">16</ref> We also applied ClueGO, a Cytoscape plugin, to explore the molecular function of the proteins. <ref type="bibr" target="#b16">17</ref> In the MetaboAnalyst 3.0, the pathway analysis module combines the results from powerful pathway enrichment analysis with the pathway topology analysis to help us identify the most relevant pathways involved in the conditions under this study. <ref type="bibr" target="#b17">18</ref> Using STRING 10, we generated interaction networks based on the overlapping proteins between the targets of BJF and proteomic measurements of BJF-treated rats. <ref type="bibr" target="#b18">19</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results and discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Transcriptomics analysis results of BJFtreated COPD rats</head><p>In the previous study, systems pharmacology successfully identified the bioactive ingredients and revealed the potential targets of the multiple components contained in BJF. Subsequently, we validated that BJF was effective for the treatment of COPD and ventricular hypertrophy due to its inhibitory effect on the inflammatory cytokine, and hypertrophic factors expression, protease-antiprotease imbalance and collagen deposition, in vivo. <ref type="bibr" target="#b6">7</ref> In this study, to investigate the system-wide mechanism of BJF in treating COPD rats, we further examined the effect of BJF on transcriptional profiles of lung tissues.</p><p>Using microarray-based RNA expression analysis, we detected ~41,000 expressed genes in lung tissues. There were 2,463 and 1,012 genes differently expressed at COPD model (versus control) and BJF treatment (versus COPD model) rats, respectively (Tables S1 and S2). These transcripts regulated in lung tissues of COPD model rats could be mapped to various molecular functions such as regulation of oxidoreductase activity, nucleic acid binding, channel activity, fatty acid binding, glucose, or fatty acid metabolism ( <ref type="figure" target="#fig_0">Figure 1A</ref>). However, transcripts regulated only in BJFtreated rats were mapped to several molecular functions, such as kinase binding, protein complex binding, and insulin receptor binding ( <ref type="figure" target="#fig_0">Figure 1B)</ref>.</p><p>In addition, in the COPD model group, the regulated genes were mapped to many different pathways, such as fatty acid metabolism, valine, leucine and isoleucine degradation, and propanoate metabolism ( <ref type="table" target="#tab_1">Table 1</ref>). The genes regulated in the BJF-treated group could be mapped to adherens junction, focal adhesion, endocytosis, wnt signaling pathway, etc. <ref type="table" target="#tab_2">(Table 2)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Proteomics analysis results of BJF-treated COPD rats</head><p>To characterize the protein expression profiles of rats, expression levels of proteins were detected using LC-MSbased proteomics. Comparing to those in healthy control rats, 192 proteins were identified in the COPD model rats <ref type="table" target="#tab_3">(Table S3</ref>). After the treatment with BJF, comparing to those in the COPD model rats, 191 proteins were detected in BJF-treated rats <ref type="table" target="#tab_4">(Table S4</ref>). The COPD rats (192 proteins) shared 100 common proteins with the BJF-treated rats (191 proteins). Out of the 100 proteins, expression changes of 42 proteins in the COPD model were inhibited by the BJF treatment <ref type="table" target="#tab_5">(Table S5</ref>). These 42 proteins could be attributed to various molecular functions, such as oxidoreductase activity and antioxidant activity (peroxidase activity, catalase activity, thioredoxin peroxidase activity; <ref type="figure" target="#fig_1">Figure 2A</ref>), which might be involved in the therapeutic mechanism of BJF in treating COPD.</p><p>In addition, the 192 proteins regulated in COPD rats could be attributed to multiple molecular functions, including phospholipase A2 inhibitor activity, peroxiredoxin activity, and oxidoreductase activity, acting on the aldehyde or oxo group of donors, etc. ( <ref type="figure" target="#fig_1">Figure 2B</ref>). In the BJF-treated group, 191 regulated proteins were mainly related to oxidoreductase activity, adrenergic receptor activity, receptor signaling protein activity, and extracellular ligand-gated ion channel activity ( <ref type="figure" target="#fig_1">Figure 2C</ref>).</p><p>In addition, the proteins regulated in COPD rats and BJF-treated rats were mapped to various pathways, such as focal adhesion, tight junction, adherens junction, and leukocyte trans-endothelial migration <ref type="table" target="#tab_3">(Tables 3 and 4)</ref>.</p><p>COPD is known to be accompanied by pulmonary inflammation, oxidative stress, and muscle fiber dysfunction. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21</ref> These results suggested that BJF treatment could improve these COPD symptoms probably by regulating multiple molecular functions and pathways, such as oxidoreductase and antioxidant activity, focal adhesion, tight junction, adherens junction, and leukocyte trans-endothelial migration pathway.</p><p>holistic views on gene, protein, and metabolite data</p><p>In the previous study, we detected 49 and 30 metabolites regulated in the COPD model (versus control) and BJFtreated (versus COPD model) groups, respectively. <ref type="bibr" target="#b12">13</ref> These metabolites were primarily involved in lipid metabolism ( <ref type="figure" target="#fig_2">Figure 3A and B)</ref>. In this study, a number of genes and proteins were identified, which deserve further attention to their system functions. Therefore, we further explored the system biological interpretation of the genes, proteins, and metabolites by integrating transcriptomics, proteomics, and metabolomics data.</p><p>Using the Metscape software, we investigated the latent relationships of the metabolite, gene, and protein measurements by constructing the correlation network diagram. As shown in <ref type="figure" target="#fig_3">Figure 4A</ref> and B, according to the transcriptomics and metabolomics data of COPD rats and BJF-treated rats, we constructed two gene-metabolite networks, which were mainly related to lipid metabolism and purine metabolism. Interestingly, a number of genes and most of the metabolites were involved in lipid metabolism. Subsequently, we constructed two protein-metabolite networks based on the metabolomics and proteomics data of COPD rats and BJFtreated rats. As shown in <ref type="figure" target="#fig_3">Figure 4C</ref> and D, we observed that the protein-metabolite networks could be divided into two primary groups: lipid metabolism and purine metabolism, and more than half of proteins and almost all of metabolites were involved in lipid metabolism.  All of the abovementioned results indicated that lipid metabolism disorders might play a critical role in the COPD development and BJF intervention in a preclinical setting.</p><p>To explore the system relationships of the transcript and protein measurements, we compared the significant pathways derived from transcriptomics and proteomics data of COPD rats, and identified three common pathways including fatty acid metabolism, propanoate metabolism, and valine, leucine, and isoleucine degradation <ref type="table" target="#tab_1">(Tables 1 and 3</ref>). In addition, the transcripts and proteins regulated in BJF-treated rats were mapped into three common pathways: adherens junction, tight junction, regulation of actin cytoskeleton, and dilated cardiomyopathy <ref type="table" target="#tab_2">(Tables 2 and 4</ref>).     Integrating systems pharmacology, transcriptomics, proteomics, and metabolomics data</p><p>In the previous study, systems pharmacology successfully identified 175 targets of the active compounds contained in BJF. <ref type="bibr" target="#b6">7</ref> To investigate the system mechanism of BJF in treating COPD, we integrated transcriptomics, proteomics, and metabolomics data streams with systems pharmacology to provide a globe view of therapeutic mechanism of BJF treatment.</p><p>In this article, we first analyzed the overlapping proteins between the targets of BJF and transcript measurements of BJF-treated rats. As shown in <ref type="figure" target="#fig_4">Figure 5A</ref>, there were seven overlapping proteins (VEGFA, SLC6A2, ADRA2B, gyrB, CYCS, ampC, and katA) between them, which were associated with various biological functions, such as vascular endothelial growth factor receptor 1 binding, chemoattractant activity, and G-protein-coupled amine receptor activity. Subsequently, we identified eleven overlapping proteins <ref type="figure" target="#fig_0">(GSTM1, GSTP1, CTSD, MPO, HSPA5, CAT, ampC, kata,  XDH, SOD1, and gyrB)</ref> between the targets of BJF and proteomic measurements of BJF-treated rats. Interestingly, the molecular functions of eleven overlapping proteins were mainly related to oxidoreductase and antioxidant activity ( <ref type="figure" target="#fig_4">Figure 5B</ref>). However, no overlapping pathways were detected between the potential targets and transcript/protein measurements of BJF-treated rats. Finally, we constructed a correlation network diagram to investigate the latent relationships of the potential targets and metabolomics measurements of BJF-treated rats. In <ref type="figure" target="#fig_5">Figure 6</ref>, the results show that the network mainly consisted of lipid metabolism pathways.</p><p>As discussed earlier, we constructed a system-level picture of the therapeutic mechanism of BJF by integrating systems pharmacology, transcript, protein, and metabolite datasets. As shown in <ref type="figure" target="#fig_6">Figure 7</ref>, the systems pharmacology targets and three-omics data were integrated, and the comprehensive picture was mainly consisted of four groups: lipid metabolism, inflammatory response, cell junction, and oxidative stress. In the previous study, we found that the expression levels of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α were significantly decreased by BJF treatment. In addition, ERK, p38, JNK, and NF-κB were the potential targets of BJF. <ref type="bibr" target="#b6">7</ref> These results implied that BJF could achieve its ameliorative effect on COPD rats by suppressing inflammatory responses. In this study, upon BJF treatment, arachidonic acid metabolism and linoleic acid metabolism were the significant deregulated pathways in lung tissues. In these pathways, the level of lecithin, linoleate, 9-OXOODE, γ-linolenate, LXA4, LTB4, and PGE2 were suppressed by BJF treatment. Moreover, these metabolites, such as LXA4, LTB4, PGE2, and PGF2α, were involved in inflammatory processes in the airways of patients with COPD. <ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref> In addition, according to the systems pharmacology predictions, ALOX5 PTGS1/2, LTA4H, and AKR1C3, the important enzymes involved in these deregulated pathways were the potential targets of BJF. Therefore, the results indicated that BJF achieved its anti-inflammatory activity by suppressing the lipid metabolism and the production of pre-inflammatory cytokines.     The inflammatory responses associated with COPD are believed to be triggered by oxidative stress. <ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b26">27</ref> In this study, we detected eleven overlapping proteins between the targets of BJF and proteomic measurements of BJF-treated rats, which were mainly involved in oxidative stress. <ref type="bibr" target="#b27">28</ref> For instance, the antioxidant proteins such as SOD1 and GSTP1 were involved in the pathogenesis of COPD, <ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref> which were upregulated by BJF treatment. Additionally, increased myeloperoxidase levels are associated with rapid lung function decline. <ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33</ref> In proteomic study, we found that the expression levels of myeloperoxidase were decreased by BJF treatment. These results suggested that BJF achieved its anti-inflammatory activity by regulating the oxidative stress status.</p><p>Moreover, focal adhesion, the overlapping pathway among transcriptomic measurements, proteomic measurements, and the potential targets of BJF were significantly regulated by BJF treatment ( <ref type="table" target="#tab_5">Table 5</ref>). For instance, FAK, PI3K, JNK, c-Jun, and ERK1/2, involved in the pathogenesis of COPD progression, <ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref> were the potential targets of BJF.</p><p>Overall, we demonstrated that BJF provided protective and therapeutic benefits against COPD by regulating multiple biological functions, such as lipid metabolism, oxidative stress, inflammatory response, and focal adhesion pathway.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p>Three-omics technologies have emerged as the promising tools to find the complex mechanism of TCM in the form of systems biology. <ref type="bibr" target="#b36">37,</ref><ref type="bibr" target="#b37">38</ref> Systems pharmacology is applied to conduct a comprehensive analysis of the dynamic interactions between the components of TCM and a biological system. Combining systems pharmacology, transcriptomics, proteomics, and metabolomics data is becoming more important to detect the system-level therapeutic mechanism of TCM. However, attempts thus far to integrate system biology data streams have been met with limited success.</p><p>In this study, we first characterized the transcriptomic and proteomic profiles of the lung tissues derived from COPD rats and BJF-treated rats. The regulated transcripts and proteins were attributed to multiple functions, such as oxidoreductase activity and antioxidant activity. The metabolomics profiles of the lung tissues were previously characterized, and the regulated metabolites were mainly involved in lipid metabolism. Finally, we sought to obtain a comprehensive picture of systems pharmacology, transcriptomics, proteomics, and metabolomics data. The potential targets derived from systems pharmacology and three-omics data were integrated, and the system-level results indicated that BJF achieved its ameliorative effect over COPD via mechanisms that might be dependent on its system-wide effects on lipid metabolism, inflammatory response, cell junction pathways, and oxidative stress.</p><p>In summary, integrative application of systems pharmacology, transcriptome, proteome, and metabolome has potential implications toward understanding the system mechanism of action of TCM. </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc>Molecular functions of regulated genes in lung tissues of rats with COPD and BJF-treated rats. Notes: BingO mapped the predominant functional themes of the tested gene set on the gO hierarchy and produced an intuitive and a customizable visual representation of the results. The area of a node was proportional to the number of genes in the test set annotated to the corresponding gO category. (A) representative molecular function of regulated genes in lung tissues of rats with COPD. (B) representative molecular function of regulated genes in lung tissues of BJF-treated rats. Abbreviations: BJF, Bufei Jianpi formula; GO, gene ontology; FAD, flavin adenine dinucleotide.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>AFigure 2</head><label>2</label><figDesc>Molecular functions of regulated proteins in lung tissues of COPD rats and BJF-treated rats. Notes: BingO mapped the predominant functional themes of the 42 overlapping proteins between COPD rats and BJF-treated rats and produced an intuitive and a customizable visual representation of the results (A). The molecular functions of 192 regulated proteins in COPD rats (B), and 191 regulated proteins in BJF-treated rats (C) were analyzed by CluegO: functionally grouped network with terms as nodes linked, and functionally related groups partially overlap; the node size represents the term enrichment significance. Abbreviation: BJF, Bufei Jianpi formula.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3</head><label>3</label><figDesc>Pathway analysis of the metabolites regulated in lung tissues of COPD rats and BJF-treated rats. Notes: global metabolic disorders of the most relevant pathways were revealed using the Metaboanalyst. a google-map style interactive visualization system was implemented to facilitate data exploration and generate pathway views. (A) representative pathway analysis of the metabolites in lung tissues of COPD rats. (B) representative pathway analysis of the metabolites in lung tissues of BJF-treated rats. Abbreviation: BJF, Bufei Jianpi formula.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4</head><label>4</label><figDesc>Correlation networks of the metabolites, genes, and proteins regulated in lung tissues of COPD rats and BJF-treated rats. Notes: The compound reaction network with compounds (the pink and red hexagons) and metabolic enzymes (the gray and blue rounds) as nodes and reactions as edges, was constructed using Metscape. Inputted compounds are shown in red, inputted genes and proteins are shown in blue. existing compounds that populate the Metscape system were shown in pink. existing genes and proteins were shown in gray.(A) representative metabolites-gene network of COPD model group. (B) representative metabolite-gene network of the BJF-treated group. (C) representative metabolites-protein network of the COPD model group. (D) representative metabolite-protein network of the BJF-treated group. Abbreviation: BJF, Bufei Jianpi formula.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 5</head><label>5</label><figDesc>Molecular functions of the overlapping proteins. Notes: BingO mapped the predominant functional themes of the tested protein set on the gO hierarchy and produced an intuitive and customizable visual representation of the results. The area of a node was proportional to the number of proteins in the test set annotated to the corresponding gO category. (A) representative molecular function of overlapping proteins between the potential targets and transcript measurements in lung tissues of BJF-treated rats. (B) representative molecular function of overlapping proteins between the potential targets and proteome measurements in lung tissues of BJF-treated rats. Abbreviation: BJF, Bufei Jianpi formula.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 6</head><label>6</label><figDesc>Correlation networks of the metabolites regulated in BJF-treated rats and target proteins. Notes: The compound reaction network with compounds (the pink and red hexagons) and metabolic enzymes (the gray and blue rounds) as nodes and reactions as edges, was constructed using Metscape. Inputted compounds are shown in red, and inputted target proteins are shown in blue. existing compounds that populate the Metscape system were shown in pink. existing proteins were shown in gray. Abbreviation: BJF, Bufei Jianpi formula.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 7</head><label>7</label><figDesc>Comprehensive analysis of the potential targets of BJF, transcriptomics, proteomics, and metabolomics regulations in lung tissues of BJF-treated rats. Notes: The potential targets, transcriptomics, proteomics, and metabolomics data are presented as rectangles with different colors. red arrow stands for upregulated, blue arrow for downregulated, and gray rectangle for unregulated. Abbreviation: BJF, Bufei Jianpi formula.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1</head><label>1</label><figDesc>analyzed pathways of transcriptomics data regulated in lung tissues of rats with COPD</figDesc><table><row><cell>Term</cell><cell cols="2">Count %</cell><cell>P-value</cell></row><row><cell cols="2">Valine, leucine, and isoleucine degradation 15</cell><cell cols="2">0.1128 1.43e-06</cell></row><row><cell>Propanoate metabolism</cell><cell>12</cell><cell cols="2">0.0902 7.33e-06</cell></row><row><cell>ribosome</cell><cell>19</cell><cell cols="2">0.1429 1.02e-05</cell></row><row><cell>endocytosis</cell><cell>30</cell><cell cols="2">0.2256 1.06e-04</cell></row><row><cell>Fatty acid metabolism</cell><cell>11</cell><cell cols="2">0.0827 4.45e-04</cell></row><row><cell>graft-versus-host disease</cell><cell>12</cell><cell cols="2">0.0902 5.80e-04</cell></row><row><cell>Viral myocarditis</cell><cell>16</cell><cell cols="2">0.1203 8.03e-04</cell></row><row><cell>antigen processing and presentation</cell><cell>16</cell><cell cols="2">0.1203 9.08e-04</cell></row><row><cell>Type I diabetes mellitus</cell><cell>12</cell><cell cols="2">0.0902 0.002375</cell></row><row><cell>allograft rejection</cell><cell>11</cell><cell cols="2">0.0827 0.002977</cell></row><row><cell>aminoacyl-trna biosynthesis</cell><cell>9</cell><cell cols="2">0.0677 0.005296</cell></row><row><cell>Butanoate metabolism</cell><cell>8</cell><cell cols="2">0.0602 0.006394</cell></row><row><cell>autoimmune thyroid disease</cell><cell>11</cell><cell cols="2">0.0827 0.008398</cell></row><row><cell>Cell cycle</cell><cell>17</cell><cell cols="2">0.1278 0.012759</cell></row><row><cell>Beta-alanine metabolism</cell><cell>6</cell><cell cols="2">0.0451 0.015285</cell></row><row><cell>Other glycan degradation</cell><cell>5</cell><cell cols="2">0.0376 0.021132</cell></row><row><cell>limonene and pinene degradation</cell><cell>4</cell><cell cols="2">0.0301 0.035787</cell></row><row><cell>p53 signaling pathway</cell><cell>10</cell><cell cols="2">0.0752 0.036731</cell></row><row><cell>spliceosome</cell><cell>15</cell><cell cols="2">0.1128 0.038974</cell></row><row><cell>Pyruvate metabolism</cell><cell>7</cell><cell cols="2">0.0526 0.049506</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2</head><label>2</label><figDesc>analyzed pathways of transcriptomics data regulated in lung tissues of Bufei-Jianpi-formula-treated rats</figDesc><table><row><cell>Term renal cell carcinoma endocytosis adherens junction Focal adhesion Pathways in cancer hedgehog signaling pathway huntington's disease Protein export Wnt signaling pathway Type II diabetes mellitus</cell><cell>Count 8 14 8 13 17 6 12 3 9 5</cell><cell>% 1.5625 2.7344 1.5625 2.5391 3.3203 1.1719 2.3438 0.5859 1.7578 0.9766</cell><cell>P-value 0.002333 0.002719 0.003481 0.00587 0.01044 0.012268 0.012719 0.022752 0.040431 0.041517</cell><cell>Thioredoxin peroxidase Catalase activity activity 7-alpha-hydroxysteroid dehydrogenase activity 20-alpha-hydroxysteroid dehydrogenase activity Guanyl nucleotide binding Guanyl ribonucleotide binding GTP binding</cell><cell>Purine ribonucleotide</cell><cell>Peroxidase activity 3-alpha-hydroxysteroid dehydrogenase (B-specific) Steroid dehydrogenase activity, binding Ribonucleotide activity acting on the CH-OH group of binding donors, NAD or NADP as Oxidoreductase activity, acting on Acetoacetyl-CoA reductase acceptor peroxide as acceptor activity Peroxiredoxin activity Purine nucleotide binding Nucleotide binding Adenine binding Actin binding Misfolded protein binding Purine Oxidoreductase activity, acting on Steroid dehydrogenase Oxidoreductase activity, acting on activity the CH-OH group of donors, NAD paired donors, with incorporation or reduction of molecular oxygen Antioxidant activity Nucleobase binding Chaperone binding Virion binding Unfolded protein or NADP as acceptor binding Oxidoreductase activity, acting on binding Cytoskeletal protein binding Toxin binding</cell><cell>Catalytic activity Oxidoreductase activity Indanol dehydrogenase the CH-OH group of donors Molecular function Protein binding activity Binding ATP-dependent protein binding</cell><cell>Flavin reductase Trans-1,2-dihydrobenzene-1,2-diol activity dehydrogenase activity Biliverdin reductase activity binding Bile acid binding binding Pyridoxal phosphate Ubiquitin protein ligase or NADP as acceptor the CH-CH group of donors, NAD the CH-NH group of donors, NAD Oxidoreductase activity, acting on Oxidoreductase activity, acting on dehydrogenase activity or NADP as acceptor protein folding 3-hydroxy-2-methylbutyryl-CoA the CH-NH group of donors Oxidoreductase activity, acting on Oxidoreductase activity, acting on the CH-CH group of donors Protein binding involved in Monocarboxylic acid Enzyme binding binding Carboxylic acid binding Cofactor binding Steroid binding Vitamin D binding Vitamin binding Vitamin B6 binding Lipid binding</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3</head><label>3</label><figDesc>analyzed pathways of proteomics data regulated in lung tissues of rats with COPD</figDesc><table><row><cell>Term</cell><cell cols="2">Count %</cell><cell>P-value</cell></row><row><cell>glycolysis/gluconeogenesis</cell><cell>10</cell><cell cols="2">0.4179 6.64e-06</cell></row><row><cell>hCM</cell><cell>9</cell><cell cols="2">0.3761 5.29e-05</cell></row><row><cell>Dilated cardiomyopathy</cell><cell>9</cell><cell cols="2">0.3761 8.70e-05</cell></row><row><cell>Pyruvate metabolism</cell><cell>6</cell><cell cols="2">0.2507 3.62e-04</cell></row><row><cell cols="2">glyoxylate and dicarboxylate metabolism 4</cell><cell cols="2">0.1672 7.99e-04</cell></row><row><cell>Tight junction</cell><cell>9</cell><cell cols="2">0.3761 0.001079</cell></row><row><cell>Citrate cycle (TCa cycle)</cell><cell>5</cell><cell cols="2">0.2089 0.00125</cell></row><row><cell>leukocyte transendothelial migration</cell><cell>8</cell><cell cols="2">0.3343 0.002374</cell></row><row><cell>Focal adhesion</cell><cell>10</cell><cell cols="2">0.4179 0.003903</cell></row><row><cell>Tryptophan metabolism</cell><cell>5</cell><cell cols="2">0.2089 0.004803</cell></row><row><cell cols="2">Valine, leucine, and isoleucine degradation 5</cell><cell cols="2">0.2089 0.006122</cell></row><row><cell>adherens junction</cell><cell>6</cell><cell cols="2">0.2507 0.00651</cell></row><row><cell>Cardiac muscle contraction</cell><cell>6</cell><cell cols="2">0.2507 0.008115</cell></row><row><cell>Propanoate metabolism</cell><cell>4</cell><cell cols="2">0.1672 0.015539</cell></row><row><cell>Prion diseases</cell><cell>4</cell><cell cols="2">0.1672 0.018217</cell></row><row><cell>Fatty acid metabolism</cell><cell>4</cell><cell cols="2">0.1672 0.029489</cell></row><row><cell>arVC</cell><cell>5</cell><cell cols="2">0.2089 0.030762</cell></row><row><cell>Purine metabolism</cell><cell>7</cell><cell cols="2">0.2925 0.03707</cell></row></table><note>Abbreviations: arVC, arrhythmogenic right ventricular cardiomyopathy; hCM, hypertrophic cardiomyopathy; TCa, tricarboxylic acid.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4</head><label>4</label><figDesc>analyzed pathways of proteomics data regulated in lung tissues of Bufei-Jianpi-formula-treated rats</figDesc><table><row><cell>Term</cell><cell cols="2">Count %</cell><cell>P-value</cell></row><row><cell>Focal adhesion</cell><cell>16</cell><cell cols="2">9.0395 5.73e-07</cell></row><row><cell>Tight junction</cell><cell>13</cell><cell cols="2">7.3446 1.26e-06</cell></row><row><cell>adherens junction</cell><cell>9</cell><cell cols="2">5.0847 2.66e-05</cell></row><row><cell>regulation of actin cytoskeleton</cell><cell>14</cell><cell cols="2">7.9096 3.54e-05</cell></row><row><cell>leukocyte transendothelial migration</cell><cell>10</cell><cell cols="2">5.6497 1.09e-04</cell></row><row><cell>hCM</cell><cell>8</cell><cell cols="2">4.5198 4.49e-04</cell></row><row><cell>Dilated cardiomyopathy</cell><cell>8</cell><cell cols="2">4.5198 6.83e-04</cell></row><row><cell>eCM-receptor interaction</cell><cell>7</cell><cell cols="2">3.9548 0.002147</cell></row><row><cell>Prion diseases</cell><cell>5</cell><cell cols="2">2.8249 0.002534</cell></row><row><cell>glycolysis/gluconeogenesis</cell><cell>7</cell><cell cols="2">3.9548 0.002584</cell></row><row><cell>arVC</cell><cell>6</cell><cell cols="2">3.3898 0.007467</cell></row><row><cell>antigen processing and presentation</cell><cell>6</cell><cell cols="2">3.3898 0.01515</cell></row><row><cell>Cardiac muscle contraction</cell><cell>5</cell><cell cols="2">2.8249 0.040267</cell></row><row><cell cols="2">Valine, leucine, and isoleucine degradation 4</cell><cell cols="2">2.2599 0.040457</cell></row></table><note>Abbreviations: arVC, arrhythmogenic right ventricular cardiomyopathy; eCM, extracellular matrix; hCM, hypertrophic cardiomyopathy.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 5</head><label>5</label><figDesc>analyzed pathways of the potential target Abbreviations: als, amyotrophic lateral sclerosis; nOD, nucleotide oligomerization domain; VegF, vascular endothelial growth factor; MaPK, mitogenactivated protein kinase.</figDesc><table><row><cell>Term</cell><cell>Count</cell><cell>%</cell><cell>P-value</cell></row><row><cell>neuroactive ligand-receptor</cell><cell>28</cell><cell>0.7718</cell><cell>2.33e-11</cell></row><row><cell>interaction</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Pathways in cancer</cell><cell>26</cell><cell>0.7166</cell><cell>1.25e-07</cell></row><row><cell>Bladder cancer</cell><cell>10</cell><cell>0.2756</cell><cell>4.18e-07</cell></row><row><cell>Calcium signaling pathway</cell><cell>18</cell><cell>0.4961</cell><cell>6.48e-07</cell></row><row><cell>Prostate cancer</cell><cell>12</cell><cell>0.3308</cell><cell>6.68e-06</cell></row><row><cell>als</cell><cell>9</cell><cell>0.2481</cell><cell>2.95e-05</cell></row><row><cell>non-small-cell lung cancer</cell><cell>9</cell><cell>0.2481</cell><cell>3.39e-05</cell></row><row><cell>glioma</cell><cell>9</cell><cell>0.2481</cell><cell>1.06e-04</cell></row><row><cell>small-cell lung cancer</cell><cell>10</cell><cell>0.2756</cell><cell>1.49e-04</cell></row><row><cell>Colorectal cancer</cell><cell>10</cell><cell>0.2756</cell><cell>1.49e-04</cell></row><row><cell>gap junction</cell><cell>10</cell><cell>0.2756</cell><cell>2.33e-04</cell></row><row><cell>Pancreatic cancer</cell><cell>9</cell><cell>0.2481</cell><cell>2.73e-04</cell></row><row><cell>VegF signaling pathway</cell><cell>9</cell><cell>0.2481</cell><cell>3.63e-04</cell></row><row><cell>Metabolism of xenobiotics by</cell><cell>8</cell><cell>0.2205</cell><cell>4.93e-04</cell></row><row><cell>cytochrome P450</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Drug metabolism</cell><cell>8</cell><cell>0.2205</cell><cell>6.03e-04</cell></row><row><cell>Progesterone-mediated oocyte</cell><cell>9</cell><cell>0.2481</cell><cell>9.17e-04</cell></row><row><cell>maturation</cell><cell></cell><cell></cell><cell></cell></row><row><cell>T-cell receptor signaling pathway</cell><cell>10</cell><cell>0.2756</cell><cell>9.80e-04</cell></row><row><cell>Insulin signaling pathway</cell><cell>11</cell><cell>0.3032</cell><cell>0.001285</cell></row><row><cell>Prion diseases</cell><cell>6</cell><cell>0.1654</cell><cell>0.001287</cell></row><row><cell>Melanoma</cell><cell>8</cell><cell>0.2205</cell><cell>0.001367</cell></row><row><cell>gnrh signaling pathway</cell><cell>9</cell><cell>0.2481</cell><cell>0.002145</cell></row><row><cell>Focal adhesion</cell><cell>13</cell><cell>0.3583</cell><cell>0.002765</cell></row><row><cell>nOD-like receptor signaling pathway</cell><cell>7</cell><cell>0.1929</cell><cell>0.003321</cell></row><row><cell>erbB signaling pathway</cell><cell>8</cell><cell>0.2205</cell><cell>0.004394</cell></row><row><cell>Thyroid cancer</cell><cell>5</cell><cell>0.1378</cell><cell>0.004572</cell></row><row><cell>Type II diabetes mellitus</cell><cell>6</cell><cell>0.1654</cell><cell>0.004846</cell></row><row><cell>alzheimer's disease</cell><cell>11</cell><cell>0.3032</cell><cell>0.005136</cell></row><row><cell>endometrial cancer</cell><cell>6</cell><cell>0.1654</cell><cell>0.007473</cell></row><row><cell>arginine and proline metabolism</cell><cell>6</cell><cell>0.1654</cell><cell>0.008098</cell></row><row><cell>neurotrophin signaling pathway</cell><cell>9</cell><cell>0.2481</cell><cell>0.008989</cell></row><row><cell>Toll-like receptor signaling pathway</cell><cell>8</cell><cell>0.2205</cell><cell>0.009847</cell></row><row><cell>arachidonic acid metabolism</cell><cell>6</cell><cell>0.1654</cell><cell>0.010189</cell></row><row><cell>graft-versus-host disease</cell><cell>5</cell><cell>0.1378</cell><cell>0.013197</cell></row><row><cell>Oocyte meiosis</cell><cell>8</cell><cell>0.2205</cell><cell>0.015298</cell></row><row><cell>Vascular smooth muscle contraction</cell><cell>8</cell><cell>0.2205</cell><cell>0.016754</cell></row><row><cell>apoptosis</cell><cell>7</cell><cell>0.1929</cell><cell>0.016888</cell></row><row><cell>p53 signaling pathway</cell><cell>6</cell><cell>0.1654</cell><cell>0.022214</cell></row><row><cell>renal cell carcinoma</cell><cell>6</cell><cell>0.1654</cell><cell>0.024849</cell></row><row><cell>Cell cycle</cell><cell>8</cell><cell>0.2205</cell><cell>0.028683</cell></row><row><cell>glutathione metabolism</cell><cell>5</cell><cell>0.1378</cell><cell>0.030289</cell></row><row><cell>Fc epsilon rI signaling pathway</cell><cell>6</cell><cell>0.1654</cell><cell>0.037359</cell></row><row><cell>MaPK signaling pathway</cell><cell>12</cell><cell>0.3308</cell><cell>0.0418</cell></row></table><note></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">International Journal of COPD 2016:11 submit your manuscript | www.dovepress.comDovepress Dovepress</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">International Journal of COPD 2016:11 submit your manuscript | www.dovepress.comDovepressDovepressDovepress</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p>The research is supported by the National Natural Science Fund of China (influence and long-term effects of three Tiao-Bu Fei-Shen therapies in rats with COPD on regulation of multidimensional molecular network, No 81130062).</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors contributions</head><p>JSL and SYL designed the outline of the study. PZ performed experiments, conceived the study, wrote the draft of the manuscript, and revised the manuscript. LPY, YGT, and YL were involved in performing experiments, acquisition of data, and statistical analysis. All authors contributed toward data analysis, drafting and critically revising the paper and agree to be accountable for all aspects of the work. All the authors read and approved the final version of the manuscript.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure</head><p>The authors report no conflicts of interest in this study.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>International Journal of COPD</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Publish your work in this journal</head><p>Submit your manuscript here: http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journal</p><p>The International Journal of COPD is an international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus is given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols.</p><p>This journal is indexed on PubMed Central, MedLine and CAS. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jørgen</forename><surname>Vestbo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suzanne</forename><forename type="middle">S</forename><surname>Hurd</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alvar</forename><forename type="middle">G</forename><surname>Agustí</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">W</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Claus</forename><surname>Vogelmeier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonio</forename><surname>Anzueto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">J</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leonardo</forename><forename type="middle">M</forename><surname>Fabbri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fernando</forename><forename type="middle">J</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaharu</forename><surname>Nishimura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">A</forename><surname>Stockley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Don</forename><forename type="middle">D</forename><surname>Sin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberto</forename><surname>Rodriguez-Roisin</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.201204-0596pp</idno>
		<idno type="PMID">22878278</idno>
		<ptr type="open-access" target="http://ajrccm.atsjournals.org/content/187/4/347.full.pdf+html" />
	</analytic>
	<monogr>
		<title level="j">American Journal of Respiratory and Critical Care Medicine</title>
		<title level="j" type="abbrev">Am J Respir Crit Care Med</title>
		<idno type="ISSN">1073-449X</idno>
		<idno type="ISSNe">1535-4970</idno>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="347" to="365" />
			<date type="published" when="2013-02-15" />
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Profiling of Sputum Inflammatory Mediators in Asthma and Chronic Obstructive Pulmonary Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Bafadhel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Mccormick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Saha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Mckenna</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Shelley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Hargadon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Mistry</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Reid</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Dodson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Jenkins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Lloyd</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Rugman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><surname>Newbold</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">E</forename><surname>Brightling</surname></persName>
		</author>
		<idno type="DOI">10.1159/000330667</idno>
		<idno type="PMID">21912093</idno>
		<idno type="PMCID">PMC3417284</idno>
	</analytic>
	<monogr>
		<title level="j">Respiration</title>
		<title level="j" type="abbrev">Respiration</title>
		<idno type="ISSN">0025-7931</idno>
		<idno type="ISSNe">1423-0356</idno>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="36" to="44" />
			<date type="published" when="2011-09-07" />
			<publisher>S. Karger AG</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Prescott</forename><forename type="middle">G</forename><surname>Woodruff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alvar</forename><surname>Agusti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicolas</forename><surname>Roche</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dave</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fernando</forename><forename type="middle">J</forename><surname>Martinez</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(15)60693-6</idno>
		<idno type="PMID">25943943</idno>
		<idno type="PMCID">PMC4869530</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc4869530?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<title level="j" type="abbrev">The Lancet</title>
		<idno type="ISSN">0140-6736</idno>
		<imprint>
			<biblScope unit="volume">385</biblScope>
			<biblScope unit="issue">9979</biblScope>
			<biblScope unit="page" from="1789" to="1798" />
			<date type="published" when="2015-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Su-Yun</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian-Sheng</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ming-Hang</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yang</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xue-Qing</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zi-Kai</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Li-Jun</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hai-Long</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fan</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ying-Chao</forename><surname>Pan</surname></persName>
		</author>
		<idno type="DOI">10.1186/1472-6882-12-197</idno>
		<idno type="PMID">23107470</idno>
		<idno type="PMCID">PMC3528455</idno>
		<ptr type="open-access" target="https://bmccomplementalternmed.biomedcentral.com/track/pdf/10.1186/1472-6882-12-197" />
	</analytic>
	<monogr>
		<title level="j">BMC Complementary and Alternative Medicine</title>
		<title level="j" type="abbrev">BMC Complement Altern Med</title>
		<idno type="ISSNe">1472-6882</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">197</biblScope>
			<date type="published" when="2012-10-29" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Network Systems Underlying Traditional Chinese Medicine Syndrome and Herb Formula</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shao</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.2174/157489309789071129</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/ce30/8736c07d166ead9f8b36d8b654f7308c7dad.pdf" />
	</analytic>
	<monogr>
		<title level="j">Current Bioinformatics</title>
		<title level="j" type="abbrev">CBIO</title>
		<idno type="ISSN">1574-8936</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="188" to="196" />
			<date type="published" when="2009-09-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The rediscovery of ancient Chinese herbal formulas</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei</forename><surname>Jia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wen-Yuan</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yong-Qing</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jie</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhao-Hui</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wen-Jie</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pei-Gen</forename><surname>Xiao</surname></persName>
		</author>
		<idno type="DOI">10.1002/ptr.1506</idno>
		<idno type="PMID">15476313</idno>
		<idno type="ark">ark:/67375/WNG-9PHB64FL-9</idno>
		<idno type="istexId">5216D76A988DB0BDB6F8F98DADC38725AE53E6B5</idno>
	</analytic>
	<monogr>
		<title level="j">Phytotherapy Research</title>
		<title level="j" type="abbrev">Phytother. Res.</title>
		<idno type="ISSN">0951-418X</idno>
		<idno type="ISSNe">1099-1573</idno>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="681" to="686" />
			<date type="published" when="2004-08" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Systems pharmacologybased approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of chronic obstructive pulmonary disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Zheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Chron Obstruct Pulmon Dis</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="2633" to="2656" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">X</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">Y</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Xu</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.can-13-0308</idno>
		<idno type="PMID">23824744</idno>
		<ptr type="open-access" target="https://cancerres.aacrjournals.org/content/canres/73/16/4992.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<title level="j" type="abbrev">Cancer Research</title>
		<idno type="ISSN">0008-5472</idno>
		<idno type="ISSNe">1538-7445</idno>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="4992" to="5002" />
			<date type="published" when="2013-07-01" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wilbert</forename><forename type="middle">Hm</forename><surname>Heijne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anne</forename><forename type="middle">S</forename><surname>Kienhuis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ben</forename><surname>Van Ommen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rob</forename><forename type="middle">H</forename><surname>Stierum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">P</forename><surname>Groten</surname></persName>
		</author>
		<idno type="DOI">10.1586/14789450.2.5.767</idno>
		<idno type="PMID">16209655</idno>
	</analytic>
	<monogr>
		<title level="j">Expert Review of Proteomics</title>
		<title level="j" type="abbrev">Expert Review of Proteomics</title>
		<idno type="ISSN">1478-9450</idno>
		<idno type="ISSNe">1744-8387</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="767" to="780" />
			<date type="published" when="2005-10" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Integrative Analysis of Transcriptomics, Proteomics, and Metabolomics Data of White Adipose and Liver Tissue of High-Fat Diet and Rosiglitazone-Treated Insulin-Resistant Mice Identified Pathway Alterations and Molecular Hubs</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Meierhofer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christopher</forename><surname>Weidner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sascha</forename><surname>Sauer</surname></persName>
		</author>
		<idno type="DOI">10.1021/pr5005828</idno>
		<idno type="PMID">25287014</idno>
		<ptr type="open-access" target="https://pure.mpg.de/pubman/item/item_2072992_2/component/file_2072991/pr_Meierhofer.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Proteome Research</title>
		<title level="j" type="abbrev">J. Proteome Res.</title>
		<idno type="ISSN">1535-3893</idno>
		<idno type="ISSNe">1535-3907</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="5592" to="5602" />
			<date type="published" when="2014-10-28" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Integrated metabolome and transcriptome analysis of the NCI60 dataset</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gang</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><forename type="middle">F</forename><surname>Burant</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christopher</forename><forename type="middle">W</forename><surname>Beecher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brian</forename><forename type="middle">D</forename><surname>Athey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fan</forename><surname>Meng</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2105-12-s1-s36</idno>
		<idno type="PMID">21342567</idno>
		<idno type="PMCID">PMC3044292</idno>
		<ptr type="open-access" target="https://bmcbioinformatics.biomedcentral.com/track/pdf/10.1186/1471-2105-12-S1-S36" />
	</analytic>
	<monogr>
		<title level="j">BMC Bioinformatics</title>
		<title level="j" type="abbrev">BMC Bioinformatics</title>
		<idno type="ISSN">1471-2105</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">Suppl 1</biblScope>
			<biblScope unit="page">S36</biblScope>
			<date type="published" when="2011" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Visualization of omics data for systems biology</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nils</forename><surname>Gehlenborg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Seán</forename><forename type="middle">I</forename><surname>O'donoghue</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nitin</forename><forename type="middle">S</forename><surname>Baliga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Goesmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthew</forename><forename type="middle">A</forename><surname>Hibbs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroaki</forename><surname>Kitano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Oliver</forename><surname>Kohlbacher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Heiko</forename><surname>Neuweger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Reinhard</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dan</forename><surname>Tenenbaum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anne-Claude</forename><surname>Gavin</surname></persName>
		</author>
		<idno type="DOI">10.1038/nmeth.1436</idno>
		<idno type="PMID">20195258</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Methods</title>
		<title level="j" type="abbrev">Nat Methods</title>
		<idno type="ISSN">1548-7091</idno>
		<idno type="ISSNe">1548-7105</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="S56" to="S68" />
			<date type="published" when="2010-03" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Metabolomics study on model rats of chronic obstructive pulmonary disease treated with Bu-Fei Jian-Pi</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jiansheng</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Liping</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">A</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yange</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suyun</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suli</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ying</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xinmin</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.3892/mmr.2014.2843</idno>
		<idno type="PMID">25370181</idno>
		<ptr type="open-access" target="http://www.spandidos-publications.com/10.3892/mmr.2014.2843/download" />
	</analytic>
	<monogr>
		<title level="j">Molecular Medicine Reports</title>
		<idno type="ISSN">1791-2997</idno>
		<idno type="ISSNe">1791-3004</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="1324" to="1333" />
			<date type="published" when="2014-11-03" />
			<publisher>Spandidos Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">A Rat Model for Stable Chronic Obstructive Pulmonary Disease Induced by Cigarette Smoke Inhalation and Repetitive Bacterial Infection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ya</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Su-Yun</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian-Sheng</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Li</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yan-Ge</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Su-Li</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ying</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuan-Yuan</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1248/bpb.b12-00407</idno>
		<idno type="PMID">22863994</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/bpb/35/10/35_b12-00407/_pdf" />
	</analytic>
	<monogr>
		<title level="j">Biological and Pharmaceutical Bulletin</title>
		<title level="j" type="abbrev">Biol. Pharm. Bull.</title>
		<idno type="ISSN">0918-6158</idno>
		<idno type="ISSNe">1347-5215</idno>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1752" to="1760" />
			<date type="published" when="2012" />
			<publisher>Pharmaceutical Society of Japan</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Maere</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Heymans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Kuiper</surname></persName>
		</author>
		<idno type="DOI">10.1093/bioinformatics/bti551</idno>
		<idno type="PMID">15972284</idno>
		<idno type="ark">ark:/67375/HXZ-QD3DCFX5-0</idno>
		<idno type="istexId">D0F0BC154DA3532B59E16BA0DD85DDCA3D7EC398</idno>
		<ptr type="open-access" target="https://academic.oup.com/bioinformatics/article-pdf/21/16/3448/573651/bti551.pdf" />
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<title level="j" type="abbrev">Bioinformatics</title>
		<idno type="ISSN">1367-4803</idno>
		<idno type="ISSNe">1460-2059</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="3448" to="3449" />
			<date type="published" when="2005-06-21" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alla</forename><surname>Karnovsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Terry</forename><surname>Weymouth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tim</forename><surname>Hull</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">Glenn</forename><surname>Tarcea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><surname>Scardoni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlo</forename><surname>Laudanna</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maureen</forename><forename type="middle">A</forename><surname>Sartor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kathleen</forename><forename type="middle">A</forename><surname>Stringer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">V</forename><surname>Jagadish</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><surname>Burant</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brian</forename><surname>Athey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gilbert</forename><forename type="middle">S</forename><surname>Omenn</surname></persName>
		</author>
		<idno type="DOI">10.1093/bioinformatics/btr661</idno>
		<idno type="PMID">22135418</idno>
		<idno type="PMCID">PMC3268237</idno>
		<ptr type="open-access" target="https://academic.oup.com/bioinformatics/article-pdf/28/3/373/16908662/btr661.pdf" />
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<idno type="ISSN">1367-4803</idno>
		<idno type="ISSNe">1460-2059</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="373" to="380" />
			<date type="published" when="2011-11-30" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gabriela</forename><surname>Bindea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bernhard</forename><surname>Mlecnik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hubert</forename><surname>Hackl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pornpimol</forename><surname>Charoentong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marie</forename><surname>Tosolini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Amos</forename><surname>Kirilovsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wolf-Herman</forename><surname>Fridman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Franck</forename><surname>Pagès</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zlatko</forename><surname>Trajanoski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jérôme</forename><surname>Galon</surname></persName>
		</author>
		<idno type="DOI">10.1093/bioinformatics/btp101</idno>
		<idno type="PMID">19237447</idno>
		<idno type="PMCID">PMC2666812</idno>
		<ptr type="open-access" target="https://academic.oup.com/bioinformatics/article-pdf/25/8/1091/16892437/btp101.pdf" />
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<idno type="ISSN">1367-4803</idno>
		<idno type="ISSNe">1460-2059</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1091" to="1093" />
			<date type="published" when="2009-02-23" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">MetaboAnalyst 3.0—making metabolomics more meaningful</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jianguo</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Igor</forename><forename type="middle">V</forename><surname>Sinelnikov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Beomsoo</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">S</forename><surname>Wishart</surname></persName>
		</author>
		<idno type="DOI">10.1093/nar/gkv380</idno>
		<idno type="PMID">25897128</idno>
		<idno type="PMCID">PMC4489235</idno>
		<ptr type="open-access" target="https://academic.oup.com/nar/article-pdf/43/W1/W251/17435854/gkv380.pdf" />
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<title level="j" type="abbrev">Nucleic Acids Res</title>
		<idno type="ISSN">0305-1048</idno>
		<idno type="ISSNe">1362-4962</idno>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">W1</biblScope>
			<biblScope unit="page" from="W251" to="W257" />
			<date type="published" when="2015-04-20" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">STRING v10: protein–protein interaction networks, integrated over the tree of life</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Damian</forename><surname>Szklarczyk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrea</forename><surname>Franceschini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stefan</forename><surname>Wyder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kristoffer</forename><surname>Forslund</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Davide</forename><surname>Heller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaime</forename><surname>Huerta-Cepas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Milan</forename><surname>Simonovic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alberto</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kalliopi</forename><forename type="middle">P</forename><surname>Tsafou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Kuhn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peer</forename><surname>Bork</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lars</forename><forename type="middle">J</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christian</forename><surname>Von mering</surname></persName>
		</author>
		<idno type="DOI">10.1093/nar/gku1003</idno>
		<idno type="PMID">25352553</idno>
		<idno type="PMCID">PMC4383874</idno>
		<ptr type="open-access" target="https://academic.oup.com/nar/article-pdf/43/D1/D447/7311163/gku1003.pdf" />
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<idno type="ISSN">0305-1048</idno>
		<idno type="ISSNe">1362-4962</idno>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">D1</biblScope>
			<biblScope unit="page" from="D447" to="D452" />
			<date type="published" when="2014-10-28" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Pathogenesis of Chronic Obstructive Pulmonary Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Macnee</surname></persName>
		</author>
		<idno type="DOI">10.1513/pats.200504-045sr</idno>
		<idno type="PMID">16267346</idno>
		<idno type="PMCID">PMC2713323</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2713323?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the American Thoracic Society</title>
		<title level="j" type="abbrev">Proceedings of the American Thoracic Society</title>
		<idno type="ISSN">1546-3222</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="258" to="266" />
			<date type="published" when="2005-11-01" />
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">COPD: current therapeutic interventions and future approaches</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Stockley</surname></persName>
		</author>
		<idno type="DOI">10.1183/09031936.05.00139104</idno>
		<idno type="PMID">15929966</idno>
		<ptr type="open-access" target="http://erj.ersjournals.com/content/25/6/1084.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">European Respiratory Journal</title>
		<title level="j" type="abbrev">European Respiratory Journal</title>
		<idno type="ISSN">0903-1936</idno>
		<idno type="ISSNe">1399-3003</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1084" to="1106" />
			<date type="published" when="2005-06-01" />
			<publisher>European Respiratory Society (ERS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase&amp;nbsp;have increased airway inflammation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ellen</forename><surname>Tufvesson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leif</forename><surname>Bjermer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marie</forename><surname>Ekberg</surname></persName>
		</author>
		<idno type="DOI">10.2147/copd.s78748</idno>
		<idno type="PMID">26005341</idno>
		<idno type="PMCID">PMC4427610</idno>
		<ptr type="open-access" target="https://www.dovepress.com/getfile.php?fileID=24888" />
	</analytic>
	<monogr>
		<title level="j">International Journal of Chronic Obstructive Pulmonary Disease</title>
		<title level="j" type="abbrev">COPD</title>
		<idno type="ISSNe">1178-2005</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">881</biblScope>
			<date type="published" when="2015-05" />
			<publisher>Dove Medical Press Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The role of ALOX5AP, LTA4H and LTB4R polymorphisms in determining baseline lung function and COPD susceptibility in UK smokers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Asif</forename><forename type="middle">S</forename><surname>Tulah</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stuart</forename><forename type="middle">G</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Miriam</forename><forename type="middle">F</forename><surname>Moffatt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">J</forename><surname>Wardlaw</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><forename type="middle">J</forename><surname>Connolly</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ian</forename><surname>Sayers</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2350-12-173</idno>
		<idno type="PMID">22206291</idno>
		<idno type="PMCID">PMC3267686</idno>
		<ptr type="open-access" target="https://bmcmedgenet.biomedcentral.com/track/pdf/10.1186/1471-2350-12-173" />
	</analytic>
	<monogr>
		<title level="j">BMC Medical Genetics</title>
		<title level="j" type="abbrev">BMC Med Genet</title>
		<idno type="ISSNe">1471-2350</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">173</biblScope>
			<date type="published" when="2011-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Effect of a single nucleotide polymorphism in miR-146a on COX-2 protein expression and lung function in smokers with chronic obstructive pulmonary disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Chron Obstruct Pulmon Dis</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="463" to="473" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Leukotriene B4, 8-iso-prostaglandin F2 alpha, and pH in exhaled breath condensate from asymptomatic smokers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Hoffmeyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Harth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Bunger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Bruning</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Raulf-Heimsoth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Physiol Pharmacol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="57" to="60" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Oxidative stress and redox regulation of lung inflammation in COPD</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Rahman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">M</forename><surname>Adcock</surname></persName>
		</author>
		<idno type="DOI">10.1183/09031936.06.00053805</idno>
		<idno type="PMID">16816350</idno>
		<ptr type="open-access" target="http://erj.ersjournals.com/content/28/1/219.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">European Respiratory Journal</title>
		<title level="j" type="abbrev">European Respiratory Journal</title>
		<idno type="ISSN">0903-1936</idno>
		<idno type="ISSNe">1399-3003</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="219" to="242" />
			<date type="published" when="2006-07-01" />
			<publisher>European Respiratory Society (ERS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Antioxidant pharmacological therapies for COPD</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Irfan</forename><surname>Rahman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><surname>Macnee</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.coph.2012.01.015</idno>
		<idno type="PMID">22349417</idno>
		<idno type="PMCID">PMC3768007</idno>
		<ptr type="open-access" target="https://www.pure.ed.ac.uk/ws/files/10018778/Antioxidant_pharmacological_therapies_for_COPD..pdf" />
	</analytic>
	<monogr>
		<title level="j">Current Opinion in Pharmacology</title>
		<title level="j" type="abbrev">Current Opinion in Pharmacology</title>
		<idno type="ISSN">1471-4892</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="256" to="265" />
			<date type="published" when="2012-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Oxidative Stress Levels in Exhaled Breath Condensate Associated With COPD and Smoking</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Inonu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Doruk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Sahin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Erkorkmaz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Celik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Celikel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Seyfikli</surname></persName>
		</author>
		<idno type="DOI">10.4187/respcare.01302</idno>
		<idno type="PMID">21968597</idno>
		<ptr type="open-access" target="http://rc.rcjournal.com/content/respcare/57/3/413.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Respiratory Care</title>
		<title level="j" type="abbrev">Respiratory Care</title>
		<idno type="ISSN">0020-1324</idno>
		<idno type="ISSNe">1943-3654</idno>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="413" to="419" />
			<date type="published" when="2012-03-01" />
			<publisher>Daedalus Enterprises</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Manganese superoxide dismutase is increased in the airways of smokers&apos; lungs</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Harju</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Kaarteenaho-Wiik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Sirvio</surname></persName>
		</author>
		<idno type="DOI">10.1183/09031936.04.00121203</idno>
		<idno type="PMID">15516670</idno>
		<ptr type="open-access" target="http://erj.ersjournals.com/content/24/5/765.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">European Respiratory Journal</title>
		<title level="j" type="abbrev">European Respiratory Journal</title>
		<idno type="ISSN">0903-1936</idno>
		<idno type="ISSNe">1399-3003</idno>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="765" to="771" />
			<date type="published" when="2004-11-01" />
			<publisher>European Respiratory Society (ERS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Superiority of PC-SOD to other anti-COPD drugs for elastase-induced emphysema and alteration in lung mechanics and respiratory function in mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ken-Ichiro</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keizo</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazutetsu</forename><surname>Aoshiba</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Arata</forename><surname>Azuma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tohru</forename><surname>Mizushima</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajplung.00019.2012</idno>
		<idno type="PMID">22505669</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/6a3a/2c238778a16a0f9acfacb270961a3b37e29e.pdf" />
	</analytic>
	<monogr>
		<title level="j">American Journal of Physiology-Lung Cellular and Molecular Physiology</title>
		<title level="j" type="abbrev">American Journal of Physiology-Lung Cellular and Molecular Physiology</title>
		<idno type="ISSN">1040-0605</idno>
		<idno type="ISSNe">1522-1504</idno>
		<imprint>
			<biblScope unit="volume">302</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="L1250" to="L1261" />
			<date type="published" when="2012-06-15" />
			<publisher>American Physiological Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Correlation of EPHX1, GSTP1, GSTM1, and GSTT1 genetic polymorphisms with antioxidative stress markers in chronic obstructive pulmonary disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ramzi</forename><surname>Lakhdar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sabri</forename><surname>Denden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Manel</forename><forename type="middle">Haj</forename><surname>Mouhamed</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Abdelkader</forename><surname>Chalgoum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nadia</forename><surname>Leban</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jalel</forename><surname>Knani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gérard</forename><surname>Lefranc</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Abelhadi</forename><surname>Miled</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jemni</forename><forename type="middle">Ben</forename><surname>Chibani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Amel</forename><forename type="middle">Haj</forename><surname>Khelil</surname></persName>
		</author>
		<idno type="DOI">10.3109/01902148.2010.535093</idno>
		<idno type="PMID">21309732</idno>
	</analytic>
	<monogr>
		<title level="j">Experimental Lung Research</title>
		<title level="j" type="abbrev">Experimental Lung Research</title>
		<idno type="ISSN">0190-2148</idno>
		<idno type="ISSNe">1521-0499</idno>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="195" to="204" />
			<date type="published" when="2011-02-11" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">The Relation of Serum Myeloperoxidase to Disease Progression and Mortality in Patients with Chronic Obstructive Pulmonary Disease (COPD)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hye</forename><forename type="middle">Yun</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">F Paul</forename><surname>Man</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Donald</forename><surname>Tashkin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">A</forename><surname>Wise</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">E</forename><surname>Connett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicholas</forename><forename type="middle">A</forename><surname>Anthonisen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Don</forename><forename type="middle">D</forename><surname>Sin</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0061315</idno>
		<idno type="PMID">23637811</idno>
		<idno type="PMCID">PMC3630209</idno>
		<ptr type="open-access" target="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061315&amp;type=printable" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">e61315</biblScope>
			<date type="published" when="2013-04-18" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Late Intervention with a Myeloperoxidase Inhibitor Stops Progression of Experimental Chronic Obstructive Pulmonary Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><surname>Churg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Caroline</forename><forename type="middle">V</forename><surname>Marshall</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Don</forename><forename type="middle">D</forename><surname>Sin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sarah</forename><surname>Bolton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steven</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katherine</forename><surname>Thain</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elaine</forename><forename type="middle">B</forename><surname>Cadogan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Justine</forename><surname>Maltby</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthew</forename><forename type="middle">G</forename><surname>Soars</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Philip</forename><forename type="middle">R</forename><surname>Mallinder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joanne</forename><forename type="middle">L</forename><surname>Wright</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.201103-0468oc</idno>
		<idno type="PMID">21997333</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Respiratory and Critical Care Medicine</title>
		<title level="j" type="abbrev">Am J Respir Crit Care Med</title>
		<idno type="ISSN">1073-449X</idno>
		<idno type="ISSNe">1535-4970</idno>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="34" to="43" />
			<date type="published" when="2012-01" />
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Targeting PI3K-p110alpha suppresses influenza virus infection in chronic obstructive pulmonary disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">C</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Starkey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Hanish</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="page" from="1012" to="1023" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Studies on mitogen-activated protein kinase signaling pathway in the alveolar macrophages of chronic bronchitis rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yan</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiao-Ming</forename><surname>Meng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guo-Lin</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ya-Ru</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Juan</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiong-Wen</forename><surname>Lv</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11010-014-2266-1</idno>
		<idno type="PMID">25467375</idno>
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biochemistry</title>
		<title level="j" type="abbrev">Mol Cell Biochem</title>
		<idno type="ISSN">0300-8177</idno>
		<idno type="ISSNe">1573-4919</idno>
		<imprint>
			<biblScope unit="volume">400</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="97" to="105" />
			<date type="published" when="2014-12-03" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Restoration of Corticosteroid Sensitivity in Chronic Obstructive Pulmonary Disease by Inhibition of Mammalian Target of Rapamycin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akihisa</forename><surname>Mitani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuhiro</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chaitanya</forename><surname>Vuppusetty</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">J</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicolas</forename><surname>Mercado</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.201503-0593oc</idno>
		<idno type="PMID">26426522</idno>
		<idno type="PMCID">PMC4731710</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc4731710?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">American Journal of Respiratory and Critical Care Medicine</title>
		<title level="j" type="abbrev">Am J Respir Crit Care Med</title>
		<idno type="ISSN">1073-449X</idno>
		<idno type="ISSNe">1535-4970</idno>
		<imprint>
			<biblScope unit="volume">193</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="143" to="153" />
			<date type="published" when="2016-01-15" />
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Where West Meets East: The Complex mtDNA Landscape of the Southwest and Central Asian Corridor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lluís</forename><surname>Quintana-Murci</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Raphaëlle</forename><surname>Chaix</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">Spencer</forename><surname>Wells</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Doron</forename><forename type="middle">M</forename><surname>Behar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hamid</forename><surname>Sayar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rosaria</forename><surname>Scozzari</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chiara</forename><surname>Rengo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nadia</forename><surname>Al-Zahery</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ornella</forename><surname>Semino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">Silvana</forename><surname>Santachiara-Benerecetti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alfredo</forename><surname>Coppa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Qasim</forename><surname>Ayub</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aisha</forename><surname>Mohyuddin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chris</forename><surname>Tyler-Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Qasim Mehdi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonio</forename><surname>Torroni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ken</forename><surname>Mcelreavey</surname></persName>
		</author>
		<idno type="DOI">10.1086/383236</idno>
		<idno type="PMID">15077202</idno>
		<idno type="PMCID">PMC1181978</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc1181978?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">The American Journal of Human Genetics</title>
		<title level="j" type="abbrev">The American Journal of Human Genetics</title>
		<idno type="ISSN">0002-9297</idno>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="827" to="845" />
			<date type="published" when="2004-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Metabolomics: Towards Understanding Traditional Chinese Medicine</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aihua</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hui</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhigang</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wenjun</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ping</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xijun</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1055/s-0030-1250542</idno>
		<idno type="PMID">21058239</idno>
		<ptr type="open-access" target="http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0030-1250542.pdf" />
	</analytic>
	<monogr>
		<title level="j">Planta Medica</title>
		<title level="j" type="abbrev">Planta Med</title>
		<idno type="ISSN">0032-0943</idno>
		<idno type="ISSNe">1439-0221</idno>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="2026" to="2035" />
			<date type="published" when="2010-11-05" />
			<publisher>Georg Thieme Verlag KG</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
